Acute Coronary Syndromes (ACS) News

 
 
  • No Inflammatory Benefit of CPAP for Sleep Apnea in CAD Patients Continuous positive airway pressure (CPAP) does not significantly alter levels of inflammatory biomarkers in patients with coronary artery disease (CAD) and nonsleepy obstructive sleep apnea (OSA), researchers report online October 5 in the journal Sleep.
  • TCT TCT 2017: Rich in Clinical Trials, Star Power Oscar-winner Tom Hanks headlines a conference that will feature clinical trials looking at management of left main disease, cardiogenic shock, and bioabsorbable scaffolds.
  • Dark Skies and Chest Pain as California Fires Spew Smoke 100 Miles California's deadly wildfires have darkened the skies for a hundred miles, causing respiratory problems and making it hard to see the sun not only in the state's wine country but as far as San Francisco and Sacramento.
  • No Strong Benefit of Long-term Anticoagulation in Secondary AF A preliminary study suggests little benefit on stroke reduction and a suggestion of increased bleeding from long-term anticoagulation in transient AF secondary to ACS, sepsis, or lung disease.
  • RCT in Mesothelioma Finds No Benefit From Early Palliative Care Although early palliative care was found to improve survival and quality of life in patients with lung cancer, no such benefits were seen in patients with mesothelioma.
  • Low Serum Calcium Linked to Sudden Cardiac Arrest Risk The risk of cardiac arrest more than doubled in those with the lowest calcium levels, but it's unknown how low is too low or the benefits of higher calcium intake or calcium supplementation.
  • Is CT Angiography the Best First Test for Chest Pain? A new meta-analysis shows coronary CT angiography is associated with fewer subsequent MIs than standard functional stress testing but at the cost of more downstream invasive procedures.
  • Vigorous Exercise May Be Best for Longevity in Stable CHD Observational data suggest any amount of exercise is associated with reduced mortality vs being sedentary in patients with stable CHD, but the lowest mortality was seen among the most active patients.
  • Moving the Needle in Home Cardiac-Arrest CPR, Survival Public initiatives improved bystander CPR and first-responder defibrillation in NC, but most communities don't even know how many cardiac arrests occur within their borders, let alone the outcome.
  • Most Return to Work After an MI, but 25% Don't Stay The youngest and oldest patients and those with lower socioeconomic status were most likely to have dropped out of the workforce.
  • Polysomnography Reveals 7 Types of Obstructive Sleep Apnea Polysomnography can identify 7 obstructive sleep apnea (OSA) phenotypes with differing cardiovascular implications, researchers report.
  • Stopping Long-term Aspirin Linked to CV-Event Spike The elevated risk appeared shortly after patients stopped aspirin and did not appear to diminish over time, the investigators report.
  • Cardiac Death During Triathlon 'Not Rare' In a study of more than 9 million triathlon participants over 30 years of competition, sudden death was not rare, researchers say, with most deaths seen in men over 40 and during the swim segment.
  • Age Matters When Ranking Hospitals on Acute MI Care A new study highlights the importance of including data from younger acute MI patients when ranking hospital quality, since rates for elderly patients may be quite different.
  • ESC Low LDL Target, No Clinical Gain in Non-CAD Diabetes: EMPATHY Statins aimed at reducing LDL-C to less than 70 mg/dL didn't cut cardiovascular events, but an intriguing post hoc finding suggests there may yet be benefit, in this trial of patients with diabetic retinopathy.
  • Cardiac Effects of Fingolimod in MS Reversible Fingolimod, used to treat multiple sclerosis, dampens cardiac autonomic modulation at rest and during challenges, but this effect appears to be reversible after discontinuation of the drug, a study shows.
  • AHA/ACC Issue New Performance, Quality Measures for MI The updated set includes seven new quality measures for in-house quality improvement and four new performance measures for public reporting or pay-for-performance programs.
  • Cardiac Risk the Same With All Sulfonylureas in Diabetes There is no difference in cardiac risk between nonspecific, long-acting sulfonylureas and specific, short-acting agents, although the former are more likely to provoke severe hypoglycemia.
  • ESC Data Bolster Dual Antithrombotic Therapy in AF PCI Patients A new study supports forgoing traditional triple antithrombotic therapy with aspirin for dual therapy with dabigatran and a P2Y12 inhibitor in patients with atrial fibrillation who've undergone PCI.
  • EASD Aortic Aneurysm Risk Is Smaller in Type 2 Diabetes Patients "While it's good that people with diabetes may get less" aortic aneurysm, they still need to lower blood pressure, control lipids, and stop smoking to prevent overall cardiovascular risk, an expert noted.